Strata Oncology key facts
- Operator of an oncology company intended to accelerate the impact of precision medicine for patients with cancer.
- It has raised $139.2M across 4 recorded rounds; the latest was Debt ($6.1M) in Nov 2024.
- Notable investors include Wellington Management, Cormorant Asset Management, Deerfield Management, Pfizer Ventures, MSD Global Health Innovation Fund — 14 tracked in total.
- Strata Oncology has filed 4 Form Ds with the SEC since 2016, most recently Nov 2024 ($6.1M sold to 14 investors).
- Status: Privately Held (backing).
Who backs Strata Oncology
14+- ·The complete investor list: 14 names
- ·Watch Strata Oncology: the Monday email on marks, rounds and moves
Strata Oncology funding rounds
4 roundsHow much has Strata Oncology raised?
Strata Oncology has raised $139 million in total; 4 of its rounds are on record, from 2016 on. The largest on record was a $6.3 million early-stage round in Feb 2016; the most recent was a $6.1 million debt round in Nov 2024.
Strata Oncology has filed 4 Form Ds with the SEC since 2016, most recently in Nov 2024 ($6.1 million sold to 14 investors).
Strata Oncology investors
14 investors are on record for Strata Oncology, including Wellington Management, Cormorant Asset Management, Deerfield Management and Pfizer Ventures. By type, the record holds 5 venture capital firms and 2 hedge funds. The debt round in Nov 2024 drew 14 investors.
About Strata Oncology
Operator of an oncology company intended to accelerate the impact of precision medicine for patients with cancer. The company partners with major healthcare systems across the country, which systematically send their cancer patients' biopsies to high-throughput CLIA labs for genomic sequencing, with results provided to the oncologist within days, indicating the tumor profile, and matching appropriate therapies and drug trials, enabling healthcare providers to provide actionable insight to the lives of cancer patients.
- Sector
- Healthcare
- HQ
- Ann Arbor, MI, United States
- Founded
- 2015
- Employees
- 82
- Website
- strataoncology.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Strata Oncology doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.